Healthcare provider profile · identity verified

Anna Marie Hailey-Sharp, MD

Family Practice · DE KALB, MS · NPI 1467716860

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	622	204
Omeprazole	Omeprazole	416	133
Rosuvastatin Calcium	Rosuvastatin Calcium	294	94
Atorvastatin Calcium	Atorvastatin Calcium	292	96
Gabapentin	Gabapentin	291	111
Hydrochlorothiazide	Hydrochlorothiazide	271	89
Potassium Chloride	Potassium Chloride	263	90
Losartan Potassium	Losartan Potassium	256	80
Lisinopril	Lisinopril	229	72
Furosemide	Furosemide	217	83
Glipizide	Glipizide	209	71
Levothyroxine Sodium	Levothyroxine Sodium	208	63
Pantoprazole Sodium	Pantoprazole Sodium	205	71
Meloxicam	Meloxicam	199	77
Metformin Hcl	Metformin Hcl	198	67
Hydralazine Hcl	Hydralazine Hcl	159	48
Fluticasone Propionate	Fluticasone Propionate	158	51
Eliquis	Apixaban	154	35
Albuterol Sulfate Hfa	Albuterol Sulfate	150	57
Montelukast Sodium	Montelukast Sodium	144	45
Ozempic	Semaglutide	138	31
Metoprolol Succinate	Metoprolol Succinate	120	39
Ezetimibe	Ezetimibe	118	49
Fluconazole	Fluconazole	115	75
Naproxen	Naproxen	115	43
Carvedilol	Carvedilol	110	39
Metoprolol Tartrate	Metoprolol Tartrate	106	31
Allopurinol	Allopurinol	100	34
Farxiga	Dapagliflozin Propanediol	98	31
Tamsulosin Hcl	Tamsulosin Hcl	98	38
Trazodone Hcl	Trazodone Hcl	97	29
Methocarbamol	Methocarbamol	94	45
Escitalopram Oxalate	Escitalopram Oxalate	91	23
Meclizine Hcl	Meclizine Hcl	89	38
Pravastatin Sodium	Pravastatin Sodium	88	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	87	27
Prednisone	Prednisone	84	56
Ondansetron Hcl	Ondansetron Hcl	82	28
Tizanidine Hcl	Tizanidine Hcl	81	20
Sertraline Hcl	Sertraline Hcl	79	31
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	78	57
Clonidine Hcl	Clonidine Hcl	76	20
Rybelsus	Semaglutide	70	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	26
Azithromycin	Azithromycin	64	57
Hydroxyzine Pamoate	Hydroxyzine Pamoate	56	17
Simvastatin	Simvastatin	55	18
Clopidogrel	Clopidogrel Bisulfate	54	19
Famotidine	Famotidine	54	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	50	19
Duloxetine Hcl	Duloxetine Hcl	49	16
Pregabalin	Pregabalin	49	18
Alprazolam	Alprazolam	47	suppressed
Warfarin Sodium	Warfarin Sodium	45	suppressed
Xarelto	Rivaroxaban	44	suppressed
Amoxicillin	Amoxicillin	43	37
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	11
Zolpidem Tartrate	Zolpidem Tartrate	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Colchicine	Colchicine	42	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	33
Spironolactone	Spironolactone	41	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	40	11
Esomeprazole Magnesium	Esomeprazole Magnesium	40	11
Celecoxib	Celecoxib	39	suppressed
Chlorthalidone	Chlorthalidone	39	13
Hydroxyzine Hcl	Hydroxyzine Hcl	38	11
Donepezil Hcl	Donepezil Hcl	37	11
Glipizide Er	Glipizide	37	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	37	29
Amitriptyline Hcl	Amitriptyline Hcl	36	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	13
Ventolin Hfa	Albuterol Sulfate	36	13
Linzess	Linaclotide	34	12
Promethazine Hcl	Promethazine Hcl	34	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	30
Glimepiride	Glimepiride	32	suppressed
Hydrocortisone	Hydrocortisone	31	suppressed
Ibuprofen	Ibuprofen	31	12
Tramadol Hcl	Tramadol Hcl	31	18
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	16
Jardiance	Empagliflozin	28	11
Metformin Hcl Er	Metformin Hcl	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	12
Gemfibrozil	Gemfibrozil	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Nystatin	Nystatin	27	16
Levetiracetam	Levetiracetam	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Entresto	Sacubitril/Valsartan	24	suppressed
Levofloxacin	Levofloxacin	24	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	15
Atenolol	Atenolol	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Propranolol Hcl	Propranolol Hcl	23	suppressed
Methylprednisolone	Methylprednisolone	22	19
Valsartan	Valsartan	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Topiramate	Topiramate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Clindamycin Hcl	Clindamycin Hcl	19	17
Cyproheptadine Hcl	Cyproheptadine Hcl	18	suppressed
Megestrol Acetate	Megestrol Acetate	18	suppressed
Ondansetron Odt	Ondansetron	18	12
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Estradiol	Estradiol	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Invokana	Canagliflozin	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Temazepam	Temazepam	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Finasteride	Finasteride	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error